AVR
Anteris Technologies Global Cor (AVR)
Healthcare • Medical Instruments & Supplies • $8.45 • MCap: 822,541,568
🌐
https://anteristech.com • Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Buy Decision Core
Total Score
41
Business Quality
10
Financial Strength
9
Growth Outlook
1
Momentum
4
Price Action
Current
8.45
52W High
10.57
52W Low
3.00
Above 50DMA
8.92 (-5.23%)
Above 200DMA
6.17 (37.01%)
Relative Strength
Relative Strength
0.87
RS 3M
0.42
RS 6M
0.87
RS 9M
0.85
RS 12M
1.81
Fundamentals
Revenue Growth
-0.11%
Earnings Growth
0%
ROE
-0.59%
ROA
-0.34%
Valuation
PE (Fwd)
-8.62
PEG
0
P/B
2.95
Upside
81.46%
Risk
Beta
0.73
Short %
0.09
Risk Score
9.00
Analyst
Rating
none
Target
15.33
Beta
0.73
Analysts
0
Total Score
41
Upside
81.46%
Relative Strength
0.87
Beta
0.73
Why Buy?
- PEG Ratio below 1 (attractive valuation)
- Trading above 200 DMA
- Analyst upside exceeds 15%
Key Risks
- Revenue growth is negative
- Negative ROE
Score Breakdown
Business
10
10
Financial
9
9
Growth
1
1
Valuation
10
10
Risk
3
3
Momentum
4
4
Technical
52W High: 10.57
52W Low: 3.00
Above 50DMA: -5.23%
Above 200DMA: 37.01%
Valuation
Forward PE: -8.62
PEG: 0
P/B: 2.95
Upside: 81.46%
Risk
Beta: 0.73
Short Float: 0.09%
ROE: -0.59%
ROA: -0.34%